Kevin C. Tang

2020

In 2020, Kevin C. Tang earned a total compensation of $1 as Chairman and Chief Executive Officer at Odonate Therapeutics, which was the same as previous year.

Compensation breakdown

Salary$1
Total$1
100.00%

Tang received $1 in salary, accounting for 100% of the total pay in 2020.

Rankings

In 2020, Kevin C. Tang's compensation ranked 13,088th out of 13,090 executives tracked by ExecPay.

ClassificationRankingPercentile
All
13,088
out of 13,090
0th
Division
Manufacturing
5,624
out of 5,624
0th
Major group
Chemicals And Allied Products
2,257
out of 2,257
0th
Industry group
Drugs
1,957
out of 1,957
0th
Industry
Pharmaceutical Preparations
1,462
out of 1,462
0th
Source: SEC filing on June 1, 2021.

Tang's colleagues

We found two more compensation records of executives who worked with Kevin C. Tang at Odonate Therapeutics in 2020.

2020

Joseph O'Connell

Odonate Therapeutics

Chief Medical Officer

2020

Michael Hearne

Odonate Therapeutics

Chief Financial Officer

News

You may also like